Open AccessS0715 Longer Duration of Response With Proactive Therapeutic Drug Monitoring for Infliximab but Not for Vedolizumab Treatment in Patients With Inflammatory Bowel Disease
Author(s) -
Sarmed Al Yassin,
Joseph Spataro,
Le Kang,
Jill Gaidos
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000704908.05410.59
Subject(s) - medicine , vedolizumab , infliximab , ulcerative colitis , therapeutic drug monitoring , discontinuation , inflammatory bowel disease , adverse effect , retrospective cohort study , disease , pharmacokinetics